Home » Topics » BioWorld Science

BioWorld Science
RSS

Preclinical data presented for PATrOL-enabled gene therapy candidate

March 16, 2022

New PTPN11 inhibitors identified at Sichuan Kelun-Biotech Biopharmaceutical

March 16, 2022

Aligos Therapeutics patents PD-1/PD-L1 interaction inhibitors

March 16, 2022

New orexin OX2 receptor agonists identified at Merck & Co.

March 16, 2022

Researchers develop a new Tpi1-mutated murine model of TPI deficiency

March 16, 2022

New Toll-like receptor 9 antagonists identified at Bristol Myers Squibb

March 16, 2022

Alterity Therapeutics describes zinc and/or iron ionophores

March 16, 2022

Elektrofi and Immunoprecise collaborate on self-administered formulation of PolyTope TATX-03

March 15, 2022

FDA approves IND application for SM-17 for asthma

March 15, 2022

Activating activators is strategy against apoptosis defectors

March 15, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...